日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study

长期使用肿瘤坏死因子-α抑制剂(TNF-I)与泌尿系统恶性肿瘤风险:一项多中心回顾性队列研究

Driscoll, Conor B; Rich, Jordan M; Yang, Christopher; Nicolas, Joseph; Isaacson, Dylan; Silberman, Philip; Mi, Xinlei; Ramesh Kumar, Sai Kaushik Shankar; Zhang, Hui; Belknap, Steven; Temps, William H; Schaeffer, Edward M; Kundu, Shilajit D

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy

纳武利尤单抗联合R-CHOP方案治疗初治弥漫性大B细胞淋巴瘤:安全性和疗效评价

Odetola, Oluwatobi; Ma, Shuo; Winter, Jane; Pro, Barbara; Roy, Ishan; Xie, Ping; Zhang, Bin; Chen, Qing; Koulogeorgas, George P; Mi, Xinlei; Chen, Ruohui; Ma, Yangruijue; Tang, Xiaodan; Bayer, Robert; Eisner, Robert; Nelson, Valerie; Shaikh, Habib; Tsarwhas, Dean; Saghir, Faisal; Venugopal, Parameswaran; Gordon, Leo I; Karmali, Reem

Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis

肿瘤坏死因子-α抑制剂的使用与恶性肿瘤风险:系统评价和患者水平荟萃分析

Driscoll, Conor B; Rich, Jordan M; Isaacson, Dylan; Nicolas, Joseph; Jiang, Yu; Mi, Xinlei; Yang, Christopher; Kocsuta, Victoria; Goh, Regine; Patel, Niti; Li, Eric; Siddiqui, Mohammad Rashid; Meyers, Travis; Witte, John S; Kachuri, Linda; Zhang, Hui; Beestrum, Molly; Silberman, Philip; Schaeffer, Edward M; Kundu, Shilajit D

Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort study

长期使用肿瘤坏死因子α (TNF) 抑制剂进行免疫抑制治疗与新发恶性肿瘤风险:一项多中心回顾性队列研究

Driscoll, Conor B; Rich, Jordan M; Yang, Christopher; Nicolas, Joseph; Isaacson, Dylan; Silberman, Philip; Mi, Xinlei; Kumar, Sai Kaushik Shakar Ramesh; Zhang, Hui; Belknap, Steven; Temps, William H; Schaeffer, Edward M; Kundu, Shilajit D

Drug molecular representations for drug response predictions: a comprehensive investigation via machine learning methods

基于机器学习方法的药物分子表征在药物反应预测中的应用:一项综合研究

Xiao, Meisheng; Zheng, Qianhui; Popa, Paul; Mi, Xinlei; Hu, Jianhua; Zou, Fei; Zou, Baiming

Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention.

评估间歇性服用阿司匹林预防结直肠癌的效果

Zhu Xiangzhu, Chen Ruohui, Ness Reid M, Naik Rishi D, Murff Harvey J, Zhang Heping, Xu Yanfei, Benante Kelly A, Azcarate-Peril M Andrea, Zheng Yinan, Wang Jun, Shrubsole Martha J, Su Timothy, Mi Xinlei, Kocherginsky Masha, Rodriguez Luz Maria, Della'Zanna Gary, Richmond Ellen, Hou Lifang, Khan Seema A, Dai Qi

A DEEP NEURAL NETWORK TWO-PART MODEL AND FEATURE IMPORTANCE TEST FOR SEMI-CONTINUOUS DATA

针对半连续数据的深度神经网络两部分模型及特征重要性检验

Zou, Baiming; Mi, Xinlei; Wan, Shiyu; Wu, Di; Xenakis, James G; Hu, Jianhua; Zou, Fei

An Interpretable Deep Learning Framework for Biomarker Discovery in Complex Disease Survival Outcomes

一种用于复杂疾病生存结局生物标志物发现的可解释深度学习框架

Wan, Shiyu; Mi, Xinlei; Zou, Fei; Zou, Baiming

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen

一项针对MYC异常淋巴瘤的DA-EPOCH-R联合伊沙佐米治疗的I/II期临床试验:DACIPHOR方案

Karmali, Reem; Galvez, Carlos; Hamadani, Mehdi; Gordon, Leo; Winter, Jane; Ma, Shuo; Nelson, Valerie; Fenske, Timothy S; Shah, Nirav N; Jagadeesh, Deepa; Klein, Andreas; Helenowski, Irene; Chen, Ruohui; Mi, Xinlei; Petrich, Adam; Evens, Andrew M; Pro, Barbara

Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma

胶质母细胞瘤患者的年龄分层合并症和药物分析

Rabin, Erik E; Huang, Jonathan; Kim, Miri; Mozny, Andreas; Lauing, Kristen L; Penco-Campillo, Manon; Zhai, Lijie; Bommi, Prashant; Mi, Xinlei; Power, Erica A; Prabhu, Vikram C; Anderson, Douglas E; Barton, Kevin P; Walunas, Theresa L; Schiltz, Gary E; Amidei, Christina; Sanchez-Gomez, Pilar; Thakkar, Jigisha P; Lukas, Rimas V; Wainwright, Derek A